Presentation is loading. Please wait.

Presentation is loading. Please wait.

FIGURE 1 Results for primary meta-analysis of controlled trials for the effects of walnut-enriched compared with ... FIGURE 1 Results for primary meta-analysis.

Published byCecilie Sara Kristoffersen Modified over 5 years ago

Similar presentations

Presentation on theme: "FIGURE 1 Results for primary meta-analysis of controlled trials for the effects of walnut-enriched compared with ... FIGURE 1 Results for primary meta-analysis."— Presentation transcript:

1 FIGURE 1 Results for primary meta-analysis of controlled trials for the effects of walnut-enriched compared with ... FIGURE 1 Results for primary meta-analysis of controlled trials for the effects of walnut-enriched compared with control diets on blood lipids. Randomeffects model meta-analysis for changes in total cholesterol (A), LDL cholesterol (B), HDL cholesterol (C), and triglyceride concentrations (B) in mg/dL. Conversion factors from mmol/L to mg/dL: total cholesterol, 38.67; total triglycerides, Closed rectangles and horizontal bars represent the overall estimates (difference of means) and 95% CIs for individual studies. Diamonds represent the overall estimate combining all the studies. Unless provided in the caption above, the following copyright applies to the content of this slide: © 2018 American Society for Nutrition.This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( Am J Clin Nutr, Volume 108, Issue 1, 21 June 2018, Pages 174–187, The content of this slide may be subject to copyright: please see the slide notes for details.

2 FIGURE 1 Results for primary meta-analysis of controlled trials for the effects of walnut-enriched compared with ... FIGURE 1 Results for primary meta-analysis of controlled trials for the effects of walnut-enriched compared with control diets on blood lipids. Randomeffects model meta-analysis for changes in total cholesterol (A), LDL cholesterol (B), HDL cholesterol (C), and triglyceride concentrations (B) in mg/dL. Conversion factors from mmol/L to mg/dL: total cholesterol, 38.67; total triglycerides, Closed rectangles and horizontal bars represent the overall estimates (difference of means) and 95% CIs for individual studies. Diamonds represent the overall estimate combining all the studies. Unless provided in the caption above, the following copyright applies to the content of this slide: © 2018 American Society for Nutrition.This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( Am J Clin Nutr, Volume 108, Issue 1, 21 June 2018, Pages 174–187, The content of this slide may be subject to copyright: please see the slide notes for details.

3 FIGURE 2 Results for meta-analysis of controlled trials for the effects of walnut-enriched compared with control diets ... FIGURE 2 Results for meta-analysis of controlled trials for the effects of walnut-enriched compared with control diets on apolipoproteins. Random-effects model meta-analysis for changes in apolipoprotein A (A) and apolipoprotein B (B) in mg/dL. Closed rectangles and horizontal bars represent the overall estimates (difference of means) and 95% CIs for individual studies. Diamonds represent the overall estimate combining all the studies. Unless provided in the caption above, the following copyright applies to the content of this slide: © 2018 American Society for Nutrition.This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( Am J Clin Nutr, Volume 108, Issue 1, 21 June 2018, Pages 174–187, The content of this slide may be subject to copyright: please see the slide notes for details.

Download ppt "FIGURE 1 Results for primary meta-analysis of controlled trials for the effects of walnut-enriched compared with ... FIGURE 1 Results for primary meta-analysis."

Similar presentations

Unless provided in the caption above, the following copyright applies to the content of this slide: © 2019 European Society of Cardiology and British Pharmacological.

Unless provided in the caption above, the following copyright applies to the content of this slide: © 2019 European Society of Cardiology and British Pharmacological.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
FIGURE 1 Association of habitual coffee intake with incident of CVD in the UK Biobank and in an earlier meta-analysis ... FIGURE 1 Association of habitual.

FIGURE 1 Association of habitual coffee intake with incident of CVD in the UK Biobank and in an earlier meta-analysis ... FIGURE 1 Association of habitual.
Figure 1 Data-selection process

Figure 1 Data-selection process
Figure 1 Flow diagram detailing the systematic review process.

Figure 1 Flow diagram detailing the systematic review process.
Figure 1 Schematic representation of the experimental design.

Figure 1 Schematic representation of the experimental design.
Figure 1 Mechanism of mortality benefit associated with radial access

Figure 1 Mechanism of mortality benefit associated with radial access
Figure 1 Qualitative analysis—themes and subthemes regarding detention minimisation Unless provided in the caption above, the following copyright applies.

Figure 1 Qualitative analysis—themes and subthemes regarding detention minimisation Unless provided in the caption above, the following copyright applies.
Figure 1 Number of percutaneous coronary interventions (PCI) in mainland China, 2017 (total 753 142). Data from China ... Figure 1 Number of percutaneous.

Figure 1 Number of percutaneous coronary interventions (PCI) in mainland China, 2017 (total 753 142). Data from China ... Figure 1 Number of percutaneous.
FIGURE 1 Percentage of patients with sarcopenia or low SMD across the spectrum of total adiposity (N = 3262). SMD, ... FIGURE 1 Percentage of patients.

FIGURE 1 Percentage of patients with sarcopenia or low SMD across the spectrum of total adiposity (N = 3262). SMD, ... FIGURE 1 Percentage of patients.
FIGURE 1 PRISMA flow diagram of studies in systematic review

FIGURE 1 PRISMA flow diagram of studies in systematic review
FIGURE 1 Patient enrolment flowchart. SBS, short bowel syndrome.

FIGURE 1 Patient enrolment flowchart. SBS, short bowel syndrome.
Figure 1 Phases of the research. Author’s own work.

Figure 1 Phases of the research. Author’s own work.
FIGURE 1 Flowchart of the study population.

FIGURE 1 Flowchart of the study population.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
Figure 1 The Kaplan–Meier curves of time to death post first hospitalization. hosp, hospitalization. Unless provided in the caption above, the following.

Figure 1 The Kaplan–Meier curves of time to death post first hospitalization. hosp, hospitalization. Unless provided in the caption above, the following.
AHA: American Heart Association; ALT: ...

AHA: American Heart Association; ALT: ...
Figure 1. Serum ceftazidime concentrations following intravenous administration. Unless provided in the caption above, the following copyright applies.

Figure 1. Serum ceftazidime concentrations following intravenous administration. Unless provided in the caption above, the following copyright applies.
Figure 1 A dot plot illustrating the correlation between the yearly absolute risk difference for both MACE and major ... Figure 1 A dot plot illustrating.

Figure 1 A dot plot illustrating the correlation between the yearly absolute risk difference for both MACE and major ... Figure 1 A dot plot illustrating.
Source: Figure created by the author based on data ...

Source: Figure created by the author based on data ...

Similar presentations

Ads by Google